Skip to main content

The Company hosted a presentation for analysts and investors at 13:30 CET/08:30 ET on March 16, 2023 (webcast).

"It was a year in which we prioritized our efforts in rare diseases and affirmed our commitment to our purpose of serving the unserved rare disease patient."

- Sijmen de Vries | Chief Executive Officer
Cookies: This website uses cookies Check the cookies page for more information Accept Decline